Integrating HPV testing in cervical cancer screening program: a manual for program managers
MetadataShow full item record
[Introduction]. The World Health Organization (WHO) guideline for cervical cancer screening recommends HPV testing for cervical cancer screening (WHO, 2013). Many countries, however have already established cytology (Pap smear) based screening programs, and while the scientific evidence illustrates that HPV testing is more sensitive than the Pap smear, guidance is needed on how to modify traditional screening programs to incorporate HPV testing. This guide, Integrating HPV Testing in Cervical Cancer Screening Programs: A Manual for Program Managers intends to fill this knowledge gap. It provides information on how to plan and implement a cervical cancer screening program, based on HPV testing as a primary screening test. The purpose is to provide managers with up-to-date information on HPV testing, and to facilitate strengthening cervical cancer screening programs. It provides information on the natural history of HPV, characteristics of HPV tests, and a summary of WHO recommendations on screening and treatment of precancerous cervical lesions (WHO, 2013). It also provides general information on HPV test-based cervical cancer screening program issues, such as costs, communication and education, practical laboratory information, and program monitoring. It includes information on the experiences and lessons from other countries that have already introduced HPV testing in national cervical cancer programs.
Incorporación de la prueba del virus del papiloma humano en programas de prevención de cáncer cervicouterino
Category of PAHO Strategic Plan 2014-2019
Showing items related by title, author, creator and subject.
EngenderHealth; International Agency for Research on Cancer; JHPIEGO; Program for Appropriate Technology in Health; Pan American Health Organization (Washington, D.C., AACP, 2004)[About the manual]. Unlike most other cancers, cervical cancer can be prevented through screening programs designed to identify and treat precancerous lesions. Still, more than 490,000 new cases of cervical cancer occur ...
Irwin, Kathleen L; Oberle, Mark W; Rosero-Bixby, Luis (1991)Cervical cancer and breast cancer are leading causes of cancer-related morbidity and mortality in Costa Rica. This reports results of an evaluation of cervical and breast cancer screening practices among Costa Rican women ...
Bahadoor-Yetman, A.; Riley, L.; Gibbons, A.; Fields, P. J.; Mapp-Alexander, V. (2016-04)Objective. To assess cervical cancer prevalence and associated mortality in Grenada, West Indies during 2000–2010. Methods. Records of visits to hospital and clinical facilities were obtained from the histopathology ...